Financial barriers seem to regularly impede access to critical information
Across America, women who carry genetic markers for breast cancer are leaving their doctors' offices without scheduling the tests that could save their lives — not because they lack insurance, but because insurance alone has never been the same as access. A study from Ohio State University reveals that financial uncertainty, hidden costs, and the invisible weight of competing obligations quietly erode the promise of preventive care. The finding asks a deeper question: in a system where coverage exists but clarity does not, what does it mean to truly protect someone's health?
- Even insured women at high risk for breast cancer are skipping genetic counseling, advanced imaging, and preventive surgeries because they cannot predict what their plans will actually cover.
- The burden is not abstract — women are forced to choose between cancer prevention and medical debt, childcare, or medication for illnesses already present in their households.
- Researchers found that the uncertainty of cost is itself a barrier: not knowing whether insurance will pay makes women less likely to pursue care at all.
- Underinsurance compounds the problem, as private plans frequently fail to cover the full spectrum of high-risk care, leaving women stranded between coverage and need.
- The study calls for mandatory insurance transparency on benefits and co-pays, alongside provider training to address financial assistance as a routine part of clinical conversations.
A woman learns she carries genetic markers for breast cancer. Her doctor outlines her options — counseling, imaging, possibly surgery. Then comes the question she cannot answer: what will this cost? She has insurance, but not certainty. Rather than face the maze of phone calls and surprises, she leaves without scheduling anything.
This moment, repeated in countless variations, is the subject of a study from Ohio State University published in the Journal of Genetic Counseling. Researchers interviewed fifty women identified as high-risk for breast cancer — thirty white, twenty Black — and found that financial anxiety around preventive care cuts across income levels and insurance status alike. The assumption that coverage solves access, the study suggests, is simply wrong.
The barriers are layered. Women are not weighing a single test in isolation — they are weighing it against rent, a child's needs, existing medical debt, and the cost of managing chronic illness in their families. A genetic counseling session competes for the same finite resources as everything else. Co-lead author Tasleem Padamsee described how this dynamic blocks access to the genetic information and screening most likely to catch cancer when it is still treatable.
Researcher Rachel Meadows added that underinsurance is its own quiet crisis — many women with private plans still face significant hurdles when seeking coverage for testing, counseling, or risk-reducing procedures. The insurance exists; it simply does not cover what they need.
The study's authors argue that solutions must go beyond expanding enrollment. Providers need training to discuss costs and financial assistance alongside clinical options. Regulators need to require that insurers disclose their benefits and co-pays in plain, accessible language. The women in this study understood the stakes. What they lacked was a clear financial path forward — and without it, prevention became something that happened to other people.
A woman sits in her doctor's office, told she carries genetic markers that put her at high risk for breast cancer. She nods along as the physician explains her options: genetic counseling, advanced imaging, possibly preventive surgery. Then comes the question she dreads: What will this cost? She has insurance. Good insurance, she thinks. But she doesn't know what her plan actually covers, and the prospect of finding out—of calling the insurance company, of being transferred between departments, of discovering unexpected out-of-pocket costs—feels overwhelming. So she leaves without scheduling the tests. This scene, in various forms, plays out across America, according to research from Ohio State University published in the Journal of Genetic Counseling.
The study upends a common assumption: that health insurance solves the problem of access to cancer prevention. Researchers conducted in-depth interviews with fifty women identified as high-risk for breast cancer based on family history and other clinical factors. Thirty were white; twenty were Black. What emerged was a portrait of financial anxiety that cuts across income levels and insurance status. Even women with private coverage reported struggling to afford or access the preventive care that could catch cancer early—genetic counseling, testing, advanced imaging, and in some cases, risk-reducing surgeries.
The barriers are not always what you'd expect. Yes, uninsured women face obvious obstacles. But the study found something more subtle and perhaps more troubling: insured women across the financial spectrum reported worrying about costs and avoiding steps they couldn't afford or weren't sure they could afford. The problem isn't just the price of a single test or procedure. It's that women are forced to weigh cancer prevention against other pressing financial demands—existing medical debt, childcare, treatment for chronic illnesses they or their family members already have. A genetic counseling session doesn't exist in isolation. It competes for resources with rent, with a child's school supplies, with medication for diabetes.
Tasleem Padamsee, an assistant professor at Ohio State's College of Public Health and co-lead author of the study, described the dynamic plainly: financial barriers regularly block access to the genetic information and screening that could catch cancers at their most treatable stages. For the highest-risk women, those same barriers can make preventive surgeries and medications simply unattainable. The research also identified a structural problem: lack of price transparency from insurance companies. Women reported having to guess which services their plans covered and which they didn't. This uncertainty itself becomes a barrier. If you don't know whether your insurance will pay, you're less likely to pursue the care.
Rachel Meadows, who conducted the research as a doctoral student and now works at a health outcomes research center in Fort Worth, Texas, emphasized another layer: underinsurance. Many women with private insurance still encountered significant hurdles when requesting coverage for genetic testing, counseling, risk-reducing surgeries, and enhanced screening. The insurance exists, but it doesn't cover what they need. These women are simultaneously managing current health problems and trying to prevent future ones, all while supporting children and other family members. The financial calculus becomes impossible.
The study's strength lies in its granularity. Rather than simply correlating income and insurance status with healthcare use, the researchers listened to how women actually make decisions. That texture matters. It reveals that the solution cannot be insurance alone. Padamsee argued for two kinds of change: providers need training to discuss insurance coverage, costs, and financial assistance programs alongside clinical recommendations. And regulators need to mandate that insurance companies disclose their full benefits and co-pays in clear, comprehensible language. Long-term legal protections against genetic discrimination should also be strengthened, though current law already prohibits it.
The human cost is real. Women at high risk are delaying or forgoing preventive care and early detection screening. They're making these decisions not because they don't understand the stakes, but because the financial path to prevention feels blocked. The study suggests that fixing this requires more than expanding insurance. It requires transparency, training, and a recognition that financial barriers to cancer prevention are not a problem of the uninsured alone.
Notable Quotes
Financial barriers seem to regularly impede access to critical information that high-risk women can only get through genetic counselling and testing, and keep them from using regular screenings that could catch cancers in the earliest and most treatable stages.— Tasleem Padamsee, Ohio State University
Underinsurance was a really big factor—even for those women who have private insurance, they come across a lot of hurdles with requesting coverage for genetic testing, counseling, risk-reducing surgeries and enhanced breast screening.— Rachel J. Meadows, Center for Outcomes Research at JPS Health Network
The Hearth Conversation Another angle on the story
Why does insurance not solve this problem? Aren't these women covered?
They have coverage, but it's often incomplete. Insurance exists, but it doesn't cover genetic counseling or advanced imaging or the surgeries that prevent cancer. And women don't know what they're covered for until they try to use it.
So the barrier is partly just not knowing?
Knowing is part of it, but it's deeper. Even if a woman has insurance that covers genetic testing, she might not be able to afford the co-pay because she's also paying for her child's medication or trying to pay down medical debt from something else.
She's choosing between competing needs.
Exactly. Cancer prevention isn't urgent in the way a broken bone is. It feels like a luxury when you're already stretched thin. And if you don't know whether your insurance will cover it, the uncertainty itself becomes a reason to wait.
Does this affect all women equally?
The study included both white and Black women, and the financial barriers cut across income levels. But the research doesn't fully explore whether the barriers hit differently depending on race or class. That's an open question.
What would actually fix this?
Insurance companies need to be transparent about what they cover. Doctors need to know how to talk about costs and financial help. And there needs to be a recognition that preventing cancer isn't just a medical problem—it's a financial one.